Patient | Gender | Age | Hematuria | Proteinuria | Renal Function | Hearing loss | Ocular lessions | COL4A3 Mutations |
---|---|---|---|---|---|---|---|---|
IV.1 | M | 58 | Yes | 1.08 g/24 h | Normal | Yes | No | c.998G > A; p.G333E |
IV.2 | F | 56 | No | No | Normal | No | No | c.C4382T; p.P1461L |
IV.3 | M | 62 | Yes | No | Normal | No data | No data | c.998G > A; p.G333E |
IV.4 | F | 66 | No | No | Normal | No | No data | c.A4474T; p.S1492C |
IV.6 | F | 57 | No | No | Normal | Yes | No data | N.D. |
IV.7 | M | 54 | Yes | 1.26 g/24 h | Normal | Yes | No | c.998G > A; p.G333E |
IV.9 | M | 47 | Yes | No | Normal | No data | No data | c.998G > A; p.G333E |
IV.12 | F | 50 | No | No | Normal | No | No | N.D. |
IV.19 | F | 56 | Yes | >3.5 g/24 h | CRF-dialisis | Yes | No | c.998G > A; p.G333E |
IV.21 | F | 53 | Yes | 0.9 g/24 h | Normal | Yes | No | c.998G > A; p.G333E |
V.1 | M | 31 | Yes | >3.5 g/24 h | CRF-renal transplant | Yes | No | c.998G > A; p.G333E + c.C4382T; p.P1461L |
V.2 | F | 27 | Yes | No | Normal | No | No | c.998G > A; p.G333E |
V.3 | M | 34 | Yes | >3.5 g/24 h | CRF-renal transplant | Yes | No | c.998G > A; p.G333E + c.A4474T; p.S1492C |
V.4 | M | 32 | Yes | >3.5 g/24 h | Nephrotic Syndrome | Yes | No | c.998G > A; p.G333E + c.A4474T; p.S1492C |
V.5 | F | 25 | No | No | Normal | No data | No data | N.D. |
V.10 | M | 27 | Yes | No | Normal | No | No | c.998G > A; p.G333E |
V.11 | M | 34 | No | No | Normal | No | No | N.D. |
V.14 | M | 25 | Yes | No | Normal | No data | No | c.998G > A; p.G333E |
V.16 | M | 26 | Yes | 0.35 g/24 h | Normal | Yes | No data | c.998G > A; p.G333E |